Opened the debate
The MP highlighted the potential of new cell and gene therapies to transform treatment options for patients with rare genetic conditions. She emphasised the importance of timely development, delivery and workforce readiness in ensuring equitable access to these therapies. The speech included specific examples from her constituents, Freddie and Louis, who have benefited from SMA treatments. Liz Twist called for a comprehensive strategy involving education initiatives, training programmes, and collaboration among industry, academia, and government.